| Not Yet Recruiting | Improv Music Therapy for Older Adults NCT07419022 | University of California, San Francisco | N/A |
| Not Yet Recruiting | Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI NCT07529015 | Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida) | N/A |
| Recruiting | InRAD Observational Study NCT07213700 | Stichting International Registry for Alzheimer's Disease and other Dementias Foundation | — |
| Not Yet Recruiting | Prospective Single-Arm Safety Study of Cervical LVA in AD Patients NCT07458620 | Chang Gung Memorial Hospital | Phase 1 |
| Not Yet Recruiting | A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's NCT07489599 | Qilu Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Social-cognitive Functioning: Validation of a New Neuropsychological Test NCT05558709 | Assistance Publique - Hôpitaux de Paris | N/A |
| Not Yet Recruiting | Adapting RDAD for DS NCT07425769 | University of Kansas Medical Center | N/A |
| Active Not Recruiting | Improvement of Sleep Disorders in Patients With Alzheimer's Disease After Sunlight Exposure Therapy. NCT07386808 | National Taiwan University Hospital | N/A |
| Not Yet Recruiting | Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies NCT07166744 | University Hospital, Strasbourg, France | N/A |
| Recruiting | Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease NCT07341009 | University Hospital, Caen | — |
| Recruiting | Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and NCT07239310 | Deepsonbio | N/A |
| Completed | Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease NCT07417540 | NEUROPHET | N/A |
| Recruiting | COGSCREEN II: Early Detection of Cognitive Impairment NCT07466394 | Robert Perneczky | N/A |
| Recruiting | Exploring the Utility of [18F]3F4AP for Demyelination Imaging NCT06999434 | Yale University | Phase 1 |
| Completed | A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults NCT06843824 | Institute of Psychology, Chinese Academy of Sciences | N/A |
| Completed | Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease NCT07351773 | Taizhou Second People's Hospital | N/A |
| Recruiting | [18F]ACI-19626 PET in TDP-43 Proteinopathies NCT06891716 | AC Immune SA | EARLY_Phase 1 |
| Recruiting | Quantification of Hsp90 in the Human Brain NCT07380204 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Recruiting | δ in Dementia Clinical Trials NCT05592678 | The University of Texas Health Science Center at San Antonio | N/A |
| Active Not Recruiting | Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials NCT06489015 | Protgen Ltd | EARLY_Phase 1 |
| Completed | A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Al NCT06114745 | Atridia Pty Ltd. | Phase 1 |
| Active Not Recruiting | 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease NCT07034222 | Ruijin Hospital | Phase 4 |
| Completed | Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Bo NCT05771428 | AbbVie | Phase 2 |
| Completed | A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid NCT05291234 | AbbVie | Phase 2 |
| Recruiting | Amyloid-β Clearance Mechanisms in Alzheimer's Disease NCT05059158 | Ludwig-Maximilians - University of Munich | — |
| Unknown | Effects of Auditory Brain Stimulation by "Pink Noise" on Memory Capacities in Alzheimer's Disease: Proof of Co NCT04570761 | University Hospital, Tours | N/A |
| Recruiting | UPenn Observational Research Repository on Neurodegenerative Disease NCT04715399 | University of Pennsylvania | — |
| Completed | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 NCT03802162 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease NCT07307872 | Amoneta Diagnostics SAS | — |
| Completed | Alzheimer's Disease Neuroimaging Initiative 3 NCT02854033 | University of Southern California | — |
| Unknown | Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk NCT02832921 | Sheba Medical Center | N/A |
| Completed | Trial of Oxaloacetate in Alzheimer's Disease (TOAD) NCT02593318 | Russell Swerdlow | Phase 1 |
| Completed | Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD NCT02681172 | Piramal Imaging Limited | Phase 4 |
| Terminated | Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease NCT02503501 | HealthPartners Institute | Phase 2 |
| Completed | Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients Wit NCT02531360 | Molecular NeuroImaging | EARLY_Phase 1 |
| Completed | Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer NCT02370524 | Molecular NeuroImaging | Phase 1 |
| Completed | MEMENTO-VAScular COmponents of Dementia NCT02264899 | University Hospital, Bordeaux | N/A |
| Completed | Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy S NCT02103894 | Molecular NeuroImaging | Phase 1 |
| Completed | The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms NCT01780519 | Mayo Clinic | Phase 1 |
| Completed | Alzheimer's Disease Neuroimaging Initiative 2 NCT01231971 | University of Southern California | — |